# anti10a Levels in Women Treated With LMWH in the Postpartum Period

> **NCT02856295** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 136 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** clexane (LMWH)

## Key facts

- **NCT ID:** NCT02856295
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-20
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856295, "anti10a Levels in Women Treated With LMWH in the Postpartum Period". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02856295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*